1、 SCHOLZ C. Bioadhesive polymers for drug delivery. polymers for biomedicine: synthesis, characterization, and applications[M]. John Wiley & Sons, Inc, Hoboken, NJ, USA, 2017:6. SCHOLZ C. Bioadhesive polymers for drug delivery. polymers for biomedicine: synthesis, characterization, and applications[M]. John Wiley & Sons, Inc, Hoboken, NJ, USA, 2017:6.
2、 XIAO F, DENG S, LIN L, et al. Study on absorption mechanism of dfm by using everted gut sac method[J]. Tradit Chin Drug Res Clin Pharmacol, 2010,21(6),621-624. XIAO F, DENG S, LIN L, et al. Study on absorption mechanism of dfm by using everted gut sac method[J]. Tradit Chin Drug Res Clin Pharmacol, 2010,21(6),621-624.
3、 FREDLUND L, WINIWARTER S, HILGENDORF C. In-Vitro intrinsic permeability- a transporter-independent measure of caco-2 cell permeability in drug design and development[J]. Mol Pharm, 2017, 14(5):1601. FREDLUND L, WINIWARTER S, HILGENDORF C. In-Vitro intrinsic permeability- a transporter-independent measure of caco-2 cell permeability in drug design and development[J]. Mol Pharm, 2017, 14(5):1601.
4、 ZHANG H Y, HAN Q W, XU Y F, et al. The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatin[J]. Cancer Biol Ther, 2005, 4(2):207. ZHANG H Y, HAN Q W, XU Y F, et al. The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatin[J]. Cancer Biol Ther, 2005, 4(2):207.
5、 ALSADI R M, MA T Y. IL-1β causes an increase in intestinal epithelial tight junction permeability[J]. JImmunol, 2007, 178(7):4641. ALSADI R M, MA T Y. IL-1β causes an increase in intestinal epithelial tight junction permeability[J]. JImmunol, 2007, 178(7):4641.
6、 SONIA T A, SHARMA C P. Chitosan and its derivatives for drug delivery perspective[M]//Chitosan for Biomaterials I. Springer Berlin Heidelberg, 2011: 23-53. SONIA T A, SHARMA C P. Chitosan and its derivatives for drug delivery perspective[M]//Chitosan for Biomaterials I. Springer Berlin Heidelberg, 2011: 23-53.
7、 RAWAT M, MA T Y. Lipopolysaccharide Induced Increase in CACO-2 Intestinal Tight Junction Permeability is Mediated by MIR-429 Induced Degradation of Occludin MRNA[J]. Gastroenterol, 2017, 152(5):S53. RAWAT M, MA T Y. Lipopolysaccharide Induced Increase in CACO-2 Intestinal Tight Junction Permeability is Mediated by MIR-429 Induced Degradation of Occludin MRNA[J]. Gastroenterol, 2017, 152(5):S53.
8、 XUE X M, CAO H M, YOU S S, et al. Application of nano drug delivery system to treatment of myocardial ischemia[J]. J Shanghai Jiaotong Univ,2016. XUE X M, CAO H M, YOU S S, et al. Application of nano drug delivery system to treatment of myocardial ischemia[J]. J Shanghai Jiaotong Univ,2016.
9、 IEMMA F, SPIZZIRRI U G, PUOCI F, et al. PH-sensitive hydrogels based on bovine serum albumin for oral drug delivery[J]. Int J Pharm, 2006, 312(1-2):151. IEMMA F, SPIZZIRRI U G, PUOCI F, et al. PH-sensitive hydrogels based on bovine serum albumin for oral drug delivery[J]. Int J Pharm, 2006, 312(1-2):151.
10、 NIU Z, CONEJOSSáNCHEZ I, GRIFFIN B, et al. Lipid-based nanocarriers for oral peptide delivery[J]. Adv Drug Deliv Rev, 2016, 106(Pt B):337. NIU Z, CONEJOSSáNCHEZ I, GRIFFIN B, et al. Lipid-based nanocarriers for oral peptide delivery[J]. Adv Drug Deliv Rev, 2016, 106(Pt B):337.
11、 LEADER B, BACA Q J, GOLAN D E. Protein therapeutics: a summary and pharmacological classification[J]. Nat Rev Drug Discov, 2008, 7(1):21-39. LEADER B, BACA Q J, GOLAN D E. Protein therapeutics: a summary and pharmacological classification[J]. Nat Rev Drug Discov, 2008, 7(1):21-39.
